NEPHROCAN
LIVE

Serial Number

79305387

Owner

Nephrocan Inc.

Filing Date

Nov 12, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NEPHROCAN Trademark

Serial Number: 79305387 • Registration: 6703501

NEPHROCAN is a trademark filed by Nephrocan Inc. on November 12, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 37 (Building & Construction), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Nephrocan Inc. (3 trademarks)

200-10233 153 Street,

Entity Type: 03

Nephrocan Holdings Corporation (3 trademarks)

940-1040 West Georgia Street

Entity Type: 99

Trademark Details

Filing Date

November 12, 2020

Registration Date

April 19, 2022

Published for Opposition

January 4, 2022

Goods & Services

Cloud computing featuring database management software for use in nephrology practice management; cloud computing featuring database management software for use in dialysis tracking, reporting, and billing; providing on-line non-downloadable database management software for nephrology practice management; providing on-line non-downloadable software for dialysis tracking, reporting, and billing; providing on-line, non-downloadable, internet-based software application for medical billing for physicians and health care institutions; providing temporary use of a web-based database management software application for medical practice management, namely, electronic health record management, medical billing services, dialysis tracking, dialysis reporting, dialysis billing, medical claims generation, appointment scheduling, and for remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes in the field of nephrology; hosting a website featuring non-downloadable database management software for medical practice management, namely, electronic health record management, medical billing services, dialysis tracking, dialysis reporting, dialysis billing, medical claims generation, appointment scheduling, and for remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes in the field of nephrology; software as a service (SaaS) services featuring database management software for use in nephrology practice management; software as a service (SaaS) services featuring database management software for use in dialysis tracking, reporting, and billing; consulting services in the field of kidney dialysis, namely technical consulting in the field of medical research and testing of medical preparations used in kidney dialysis and consulting in the field of technological research of medical apparatus and equipment used in kidney dialysis

Medical services, namely, dialysis centres for dialysis therapy; health care services, namely, providing after care support in the nature of nursing care, nursing services, home health care services, care management service in the nature of managed health care services, integrated healthcare services with a network of international healthcare providers; nutrition counselling; medical services for charity purposes

Maintenance, repair and technical support services related to medical products comprising medical devices and pharmaceutical and therapeutic products, namely, dialysis apparatus, dialysis instrumentation and parts therefor

Medical instruments and apparatus and medical technical devices, namely, dialysis machines, dialysis filters, hemodialysis catheters and hemodialysis catheter kits, blood line sets for hemodialysis; hemoconcentrators, namely, self-contained components that process human blood to increase the concentration of cells and proteins in the blood; medical bags for medical fluids and blood for use in dialysis; dialysis pumps; medical syringes; needles for medical use; canulae; closure caps for catheters and other parts and fittings in dialysis therapy; tubing for use in dialysis therapy; locks for catheters and other parts and fittings for use in dialysis therapy; adapters and connectors for use in connection with equipment in dialysis therapy; specialized furniture items for medial and clinical use, namely, dialysis chairs and beds

Medical preparations, namely, hemodialysis concentrate in liquid and dry powder form for use in dialysis; chemical preparations for use in forming a dialysate solution for use in dialysis; prefilled bags and cartridges with bicarbonate for use in dialysis and medical preparations for dialysis related therapy; disinfectants used in dialysis related therapy, namely, disinfectants for medical instruments and disinfectants for hygienic purposes

Business management and administration of medical facilities related to the care of renal patients; business management of dialysis centers for third parties; public policy consultancy and public advocacy services to promote awareness of kidney disease and dialysis; charitable services to promote public awareness about kidney related diseases

Educational services, namely, providing training for dialysis nurses in the field of medical dialysis services and dialysis machine engineers in the field of use of dialysis machines and related equipment

Filing History

LIMITATION OF GOODS RECEIVED FROM IB
Oct 24, 2025 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 17, 2022 FINO
NEW REPRESENTATIVE AT IB RECEIVED
Sep 9, 2022 NREP
GENERIC MADRID TRANSACTION SENT TO IB
Aug 31, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Aug 31, 2022 XXCR
CHANGE OF OWNER RECEIVED FROM IB
Jul 30, 2022 CHLD
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 19, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 19, 2022 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 16, 2022 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 2, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 4, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 4, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Jan 1, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 15, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 15, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 15, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2021 CNSA
ASSIGNED TO EXAMINER
Nov 29, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 25, 2021 TROA
REFUSAL PROCESSED BY IB
May 23, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 27, 2021 RFCS
REFUSAL PROCESSED BY MPU
Apr 27, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 24, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 23, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 9, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 5, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 4, 2021 REPR